Alvotech Links Up With Polifarma On Proposed Eylea Biosimilar

AVT06 Is Currently Undergoing Clinical Development

Alvotech has signed an agreement with Polifarma to distribute its proposed aflibercept biosimilar in Turkey. The compound, AVT06, is currently in the development stage.

Turkish flag
Polifarma will be responsible for commercializing AVT06 in Turkey • Source: Shutterstock

More from Biosimilars

More from Products